D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 71 Citations 17,805 460 World Ranking 15204 National Ranking 7933

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

Miguel-Angel Perales focuses on Immunology, Transplantation, Internal medicine, Hematopoietic stem cell transplantation and Surgery. His work in Immunology tackles topics such as Stem cell which are related to areas like Viral replication and Virology. The concepts of his Transplantation study are interwoven with issues in Human leukocyte antigen, Chemotherapy, Retrospective cohort study and Hazard ratio.

His research in Internal medicine intersects with topics in Gastroenterology, Transplantation Conditioning and Oncology. His Hematopoietic stem cell transplantation research incorporates themes from Survival rate, Haematopoiesis and Bacteremia, Antibiotics. His biological study spans a wide range of topics, including Refractory Hodgkin Lymphoma, Adverse effect and Lymphoma.

His most cited work include:

  • Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (514 citations)
  • The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. (449 citations)
  • The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. (449 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Oncology are his primary areas of study. His work deals with themes such as Gastroenterology, CD34 and Surgery, which intersect with Internal medicine. In his study, Intensive care medicine is strongly linked to Hematopoietic cell, which falls under the umbrella field of Transplantation.

Miguel-Angel Perales has researched Hematopoietic stem cell transplantation in several fields, including Cancer, Transplantation Conditioning, Leukemia and Retrospective cohort study. Miguel-Angel Perales works mostly in the field of Oncology, limiting it down to topics relating to Chimeric antigen receptor and, in certain cases, Diffuse large B-cell lymphoma, as a part of the same area of interest. His Graft-versus-host disease study combines topics from a wide range of disciplines, such as Cyclophosphamide and Calcineurin.

He most often published in these fields:

  • Internal medicine (85.89%)
  • Transplantation (83.72%)
  • Hematopoietic stem cell transplantation (47.29%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (85.89%)
  • Transplantation (83.72%)
  • Oncology (39.84%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Transplantation, Oncology, Hematopoietic cell and Hematopoietic stem cell transplantation. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Cell therapy. His Transplantation research incorporates elements of Immune system, Immunology and Incidence, Cumulative incidence.

His Immunology research includes themes of Microbiome and Myeloablative conditioning. As a part of the same scientific study, Miguel-Angel Perales usually deals with the Oncology, concentrating on Stem cell and frequently concerns with Proteasome inhibitor and Myeloid leukemia. Within one scientific family, Miguel-Angel Perales focuses on topics pertaining to Cohort study under Hematopoietic stem cell transplantation, and may sometimes address concerns connected to Survival rate and Proportional hazards model.

Between 2019 and 2021, his most popular works were:

  • Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation (100 citations)
  • Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer. (54 citations)
  • Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial (45 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

His main research concerns Internal medicine, Transplantation, Chimeric antigen receptor, Hematopoietic stem cell transplantation and Gastroenterology. His Internal medicine study often links to related topics such as Oncology. His Transplantation research integrates issues from Hematopoietic cell, MEDLINE, Neutropenia, Clinical endpoint and Hazard ratio.

His Hematopoietic stem cell transplantation study incorporates themes from Hematology, Immunosuppression and Cohort study. The various areas that Miguel-Angel Perales examines in his Gastroenterology study include Adverse effect and Anemia. In his work, Immune system is strongly intertwined with Mycophenolate, which is a subfield of Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Ying Taur;Joao B. Xavier;Lauren Lipuma;Carles Ubeda.
Clinical Infectious Diseases (2012)

667 Citations

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

Ying Taur;Ying Taur;Robert R Jenq;Robert R Jenq;Miguel Angel Perales;Miguel Angel Perales;Eric R. Littmann.
Blood (2014)

540 Citations

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

Stefan O. Ciurea;Mei Jie Zhang;Andrea A. Bacigalupo;Asad Bashey.
Blood (2015)

470 Citations

Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease

Robert R. Jenq;Robert R. Jenq;Ying Taur;Ying Taur;Sean M. Devlin;Doris M. Ponce;Doris M. Ponce.
Biology of Blood and Marrow Transplantation (2015)

424 Citations

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.

P.J. Bergman;M.A. Camps-Palau;J.A. McKnight;N.F. Leibman.
Vaccine (2006)

315 Citations

Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease

Onder Alpdogan;Cornelius Schmaltz;Stephanie J. Muriglan;Barry J. Kappel.
Blood (2001)

298 Citations

Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.

Adam D. Cohen;Adi Diab;Miguel Angel Perales;Miguel Angel Perales;Jedd D. Wolchok;Jedd D. Wolchok.
Cancer Research (2006)

296 Citations

Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma

Craig H. Moskowitz;Matt J. Matasar;Andrew D. Zelenetz;Stephen D. Nimer.
Blood (2012)

242 Citations

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide

Asad Bashey;Mei Jie Zhang;Shannon R. McCurdy;Andrew St Martin.
Journal of Clinical Oncology (2017)

238 Citations

Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.

Abraham S. Kanate;Alberto Mussetti;Mohamed A. Kharfan-Dabaja;Kwang W. Ahn;Kwang W. Ahn.
Blood (2016)

228 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Miguel-Angel Perales

Marcel R.M. van den Brink

Marcel R.M. van den Brink

Memorial Sloan Kettering Cancer Center

Publications: 120

Mohamad Mohty

Mohamad Mohty

Université Paris Cité

Publications: 108

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 105

Xiao-Jun Huang

Xiao-Jun Huang

Peking University

Publications: 92

Bipin N. Savani

Bipin N. Savani

Vanderbilt University Medical Center

Publications: 85

Fabio Ciceri

Fabio Ciceri

Vita-Salute San Raffaele University

Publications: 75

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 74

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 69

Myriam Labopin

Myriam Labopin

Université Paris Cité

Publications: 69

Gérard Socié

Gérard Socié

Université Paris Cité

Publications: 62

Eric G. Pamer

Eric G. Pamer

University of Chicago

Publications: 57

Nicolaus Kröger

Nicolaus Kröger

Universität Hamburg

Publications: 56

Daniel J. Weisdorf

Daniel J. Weisdorf

University of Minnesota

Publications: 54

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 52

Stephanie J. Lee

Stephanie J. Lee

Fred Hutchinson Cancer Research Center

Publications: 46

Elizabeth J. Shpall

Elizabeth J. Shpall

The University of Texas MD Anderson Cancer Center

Publications: 43

Something went wrong. Please try again later.